The BH3-only protein bid does not mediate death-receptor-induced liver injury in obstructive cholestasis

American Journal of Pathology

Volumn 175, Issue 3, 2009, Pages 1077-1085

  Nalapareddy, Padmavathi Devi ^a   Schüngel, Sven ^a   Hong, Ji Young ^b   Manns, Michael P ^a   Jaeschke, Hartmut ^b   Vogel, Arndt ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BH3 PROTEIN; BILE ACID; CASPASE 3; DEATH RECEPTOR; DNA NUCLEOTIDYLEXOTRANSFERASE; FAS ANTIGEN; PROCASPASE 3; PROCASPASE 9; PROTEIN BID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT LIGATION; CHOLESTASIS; CONTROLLED STUDY; ENZYME ACTIVITY; INFLAMMATION; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; MOUSE; NICK END LABELING; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

EID: 70349243190     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.090304     Document Type: Article

References (32)

1. Higuchi H, Miyoshi H, Bronk SF, Zhang H, Dean N, Gores GJ: Bid antisense attenuates bile acid-induced apoptosis and cholestatic liver injury. J Pharmacol Exp Ther 2001, 299:866-873 (Pubitemid 33104953)
2. Takikawa Y, Miyoshi H, Rust C, Roberts P, Siegel R, Mandal PK, Millikan RE, Gores GJ: The bile acid-activated phosphatidylinositol 3-kinase pathway inhibits Fas apoptosis upstream of bid in rodent hepatocytes. Gastroenterology 2001, 120:1810-1817 (Pubitemid 32523498)
3. Yerushalmi B, Dahl R, Devereaux MW, Gumpricht E, Sokol RJ: Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition. Hepatology 2001, 33:616-626 (Pubitemid 32185224)
4. Reinehr R, Graf D, Haussinger D: Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation. Gastroenterology 2003, 125:839-853 (Pubitemid 37070701)
5. Lo Ten Foe JR, Kwee ML, Rooimans MA, Oostra AB, Veerman AJ, van Weel M, Pauli RM, Shahidi NT, Dokal I, Roberts I, Altay C, Gluckman E, Gibson RA, Mathew CG, Arwert F, Joenje H: Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. Eur J Hum Genet 1997, 5:137-148 (Pubitemid 27356701)
6. Gumpricht E, Devereaux MW, Dahl RH, Sokol RJ: Glutathione status of isolated rat hepatocytes affects bile acid-induced cellular necrosis but not apoptosis. Toxicol Appl Pharmacol 2000, 164:102-111 (Pubitemid 30198550)
7. Faubion WA, Guicciardi ME, Miyoshi H, Bronk SF, Roberts PJ, Svingen PA, Kaufmann SH, Gores GJ: Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 1999, 103:137-145 (Pubitemid 29031172)
8. Schoemaker MH, Gommans WM, de la Rosa LC, Homan M, Klok P, Trautwein C, van Goor H, Poelstra K, Haisma HJ, Jansen PL, Moshage H: Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation. J Hepatol 2003, 39:153-161 (Pubitemid 36920549)
9. Miyoshi H, Rust C, Roberts PJ, Burgart LJ, Gores GJ: Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology 1999, 117:669-677 (Pubitemid 29409254)
10. Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, Gores GJ: Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 2002, 123:1323-1330
11. Sodeman T, Bronk SF, Roberts PJ, Miyoshi H, Gores GJ: Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. Am J Physiol Gastrointest Liver Physiol 2000, 278:G992-G999 (Pubitemid 30439179)
12. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME: Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998, 17:1675-1687 (Pubitemid 28119121)
13. Li H, Zhu H, Xu CJ, Yuan J: Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998, 94:491-501 (Pubitemid 28391865)
14. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X: Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998, 94:481-490 (Pubitemid 28391864)
15. Acehan D, Jiang X, Morgan DG, Heuser JE, Wang X, Akey CW: Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol Cell 2002, 9:423-432 (Pubitemid 34195566)
16. Gujral JS, Liu J, Farhood A, Jaeschke H: Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation. Hepatology 2004, 40:998-1007 (Pubitemid 39288134)
17. Kahraman A, Barreyro FJ, Bronk SF, Werneburg NW, Mott JL, Akazawa Y, Masuoka HC, Howe CL, Gores GJ: TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse. Hepatology 2008, 47:1317-1330 (Pubitemid 351547918)
18. Takeda K, Kojima Y, Ikejima K, Harada K, Yamashina S, Okumura K, Aoyama T, Frese S, Ikeda H, Haynes NM, Cretney E, Yagita H, Sueyoshi N, Sato N, Nakanuma Y, Smyth MJ: Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease, Proc Natl Acad Sci USA 2008, 105:10895-10900
19. Gabele E, Froh M, Arteel GE, Uesugi T, Hellerbrand C, Scholmerich J, Brenner DA, Thurman RG, Rippe RA: TNF-α is required for cholestasis-induced liver fibrosis in the mouse. Biochem Biophys Res Commun 2009, 378:348-353
20. Vogel A, van Den Berg IE, Al-Dhalimy M, Groopman J, Ou CN, Ryabinina O, Iordanov MS, Finegold M, Grompe M: Chronic liver disease in murine hereditary tyrosinemia type 1 induces resistance to cell death. Hepatology 2004, 39:433-443 (Pubitemid 38222184)
21. Popov Y, Patsenker E, Fickert P, Trauner M, Schuppan D: Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes. J Hepatol 2005, 43:1045-1054 (Pubitemid 41627991)
22. Fickert P, Trauner M, Fuchsbichler A, Zollner G, Wagner M, Marschall HU, Zatloukal K, Denk H: Oncosis represents the main type of cell death in mouse models of cholestasis. J Hepatol 2005, 42:378-385 (Pubitemid 40254253)
23. Krueger A, Schmitz I, Baumann S, Krammer PH, Kirchhoff S: Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J Biol Chem 2001, 276:20633-20640 (Pubitemid 37411151)
24. Saito JM, Maher JJ: Bile duct ligation in rats induces biliary expression of cytokine-induced neutrophil chemoattractant. Gastroenterology 2000, 118:1157-1168
25. Canbay A, Feldstein AE, Higuchi H, Werneburg N, Grambihler A, Bronk SF, Gores GJ: Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology 2003, 38:1188-1198 (Pubitemid 37314827)
26. Grambihler A, Higuchi H, Bronk SF, Gores GJ: cFLIP-L inhibits p38 MAPK activation: an additional anti-apoptotic mechanism in bile acid-mediated apoptosis. J Biol Chem 2003, 278:26831-26837 (Pubitemid 36876833)
27. Canbay A, Feldstein A, Baskin-Bey E, Bronk SF, Gores GJ: The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse. J Pharmacol Exp Ther 2004, 308:1191-1196 (Pubitemid 38263997)
28. Gujral JS, Farhood A, Bajt ML, Jaeschke H: Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice. Hepatology 2003, 38:355-363 (Pubitemid 36919856)
29. Bai L, Ni HM, Chen X, DiFrancesca D, Yin XM: Deletion of Bid impedes cell proliferation and hepatic carcinogenesis. Am J Pathol 2005, 166:1523-1532 (Pubitemid 40586520)
30. Reinehr R, Sommerfeld A, Haussinger D: CD95 ligand is a proliferative and antiapoptotic signal in quiescent hepatic stellate cells. Gastroenterology 2008, 134:1494-1506 (Pubitemid 351615364)
31. Gong W, Pecci A, Roth S, Lahme B, Beato M, Gressner AM: Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand. Hepatology 1998, 28:492-502 (Pubitemid 28363678)
32. Faouzi S, Burckhardt BE, Hanson JC, Campe CB, Schrum LW, Rippe RA, Maher JJ: Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway. J Biol Chem 2001, 276:49077-49082 (Pubitemid 37370613)